episode-header-image

Aug 2021

18m 34s

Coronapod: COVID boosters amidst global ...

SPRINGER NATURE LIMITED

About this episode

Several wealthy nations have announced plans to give third vaccine doses in a bid to help increase the protection of their most vulnerable citizens - but the science is not clear on whether this strategy will be effective or indeed necessary. Meanwhile with limited vaccine supplies - billions around the world still have no access to vaccines at all. In this episode of Coronapod we discuss the science of boosters, the stark reality of vaccine disparity and what this means for the future of the pandemic.

News: COVID boosters for wealthy nations spark outrage

News feature: COVID vaccine boosters: the most important questions

Coronapod: the inequality at the heart of the pandemic

Coronapod: the biomarker that could change COVID vaccines

Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.

Hosted on Acast. See acast.com/privacy for more information.

Up next

Briefing Chat: The epic journey of Stonehenge’s central stone

In this episode:00:37 Evidence that Stonehenge's Altar Stone travelled by glacierBBC Science Focus: We may have just cracked one of Stonehenge's greatest mysteries05:44 Fossilized faeces reveal DNA from ancient ecosystemNature: Ancient ground squirrels feasted on carcasses like ‘ ... Show More

Newly-discovered whale graveyard dates back millions of years

In this episode:00:46 A giant, ancient whale necropolisResearch article: Peng et al.News & Views: A vast whale necropolis has been found08:52 Research HighlightsNature: Babies’ birth weight improves with help of payments to parentsNature: Earliest signs of vision recorded in anci ... Show More

Briefing chat: Spinosaurs with salt glands could have lived in marine environments

In this episode:00:23 Fossil evidence that spinosaurs had an aquatic lifestyleScience: Some spinosaurs cried salty tears to thrive in brackish waters04:57 The explosive immune cells that kill in minutesNature: Bang! Exploding immune cells splatter potent toxins everywhereSubscrib ... Show More

Recommended Episodes

The Evidence: When will the pandemic end?

Everybody hopes that the new super-charged Omicron variant of coronavirus will be less severe, but even if it is, it’s spreading so fast and infecting so many people, health services around the world could still buckle under the strain.Two years into the pandemic, Claudia Hammond ... Show More

The Race for a Vaccine

<p>Scientists are racing to make a vaccine for the coronavirus, collaborating across borders in what is usually a secretive and competitive field. But their cooperation has been complicated by national leaders trying to buy first claim on any breakthrough. Today, we explore how t ... Show More

Covipod #9 : Le vaccin, moins efficace chez certaines personnes

<p>Aujourd'hui, dans Covipod, nous nous penchons sur le cas des personnes que les deux doses de vaccin ne suffisent pas à protéger contre la Covid-19, et sur les mesures à prendre pour s'assurer qu'elles n'attrapent pas la maladie. Nous ferons ensuite un bref état des lieux autou ... Show More

The State of Vaccinations

<p>The United States has never undertaken a vaccination campaign of the scale and speed of the Covid-19 program. Despite a few glitches, the country appears to be on track to offer shots to all adults who want one by May 1.</p><p>We look at the ups and downs in the American vacci ... Show More

Vaccine hesitancy, the next pandemic hurdle

As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy. Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ... Show More

How close are we to a vaccine for Covid-19?

Researchers around the world are racing to develop a vaccine against Covid-19, with more than 170 candidate vaccines now in development. Most vaccines take years of testing and additional time to produce at scale, but scientists are hoping to develop a coronavirus vaccine at reco ... Show More